Publication
hema.to speeds up diagnostic workflow and improves quality
Clinical study white paper. hema.to was clinically validated in an international, four-center clinical trial. Blood cancer diagnoses were made twice as fast, with 8% more sensitivity and 10% more specificity, using hema.to’s decision-support software.